Navigation Links
Genetic Profile To Predict Ovarian Cancer Prognosis

A new study appearing in the November 1, 2005 issue of The Journal of Clinical Oncology (JCO), says that a new gene profile may help in predicting how patients with advanced ovarian cancer would respond to aggressive chemotherapy. //

In many patients with ovarian cancer, at whatever stage, first grade chemotherapy usually shows an effect in combating the cancer. But, "due to the lingering presence of chemotherapy-resistant cancer cells, most patients will unfortunately experience a relapse. The goal of our current research is to help determine which patients will relapse and which will not, and to better understand the reasons for this," says lead author Stephen A. Cannistra, MD, director of gynecologic oncology at Beth Israel Deaconess Medical Center (BIDMC) and professor of medicine at Harvard Medical School.

Cannistra and his team have been working on the genetic profile of the ovarian cancer that would help doctors predict the course of the disease as well as its prognosis in a better manner.

Last year, his team identified a gene expression profile known as the Ovarian Cancer Prognostic Profile (OCPP). This profile is helpful in predicting the survival rates of patients with advanced ovarian cancer. In the current study, researchers conducted microarray testing on 60 ovarian cancer patients treated at BIDMC and Memorial Sloan-Kettering Cancer Center to study if the genes present in the tumor before surgery find an expression the second time as well when a second-look surgery is performed. This technique is a very sensitive towards detecting any remaining cancer cells. It was found that the presence of 93 genes called, as the Chemotherapy Response Profile (CRP) was able to predict which patients would experience a complete absence of tumor the second time around. "We found that together these two gene profiles [CRP and OCPP] are a more powerful predictor of a patient's prognosis than either profile separately," said Cannistra. "This r epresents the first time that two profiles have been combined to yield such a powerful result in this disease."

Contact:

Bonnie Prescott
bprescot@bidmc.harvard.edu
Beth Israel Deaconess Medical Center
bidmc.harvard.edu

'"/>




Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Genetic influence in menopause
3. Genetics and cholesterol levels
4. Genetics helps in attacking cancer
5. Genetic disorder related with sleep patterns
6. Genetic innovation
7. Genetic tests for cancer
8. Genetic indicates memory
9. Genetic mutation to the fountain of youth discovered
10. Genetic differences found between Male and Female brains
11. Alcoholism Influenced By Both Genetics & Family Environment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival ... wardrobe. However, for those self-conscious about a double chin, this means more anxiety than ... solution. , “For most people, a double chin is undesirable,” Dr. Goldman said, ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive office ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, Conn. ...
(Date:3/28/2017)... ... 28, 2017 , ... In its ongoing effort to educate ... developed and published an informational resource that addresses frequently asked questions. , ... the site’s team of third party administrator (TPA) contributors regularly receives as employers, ...
(Date:3/28/2017)... Angeles, CA (PRWEB) , ... March 28, 2017 ... ... credential, which will be offered by the American Association of Integrative Medicine and ... presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, ... March. , The seed processing plant opened in Marshallville in 2006, and a bagging ... office allows opportunity for transition of Patten Seed operations to the Middle Georgia location ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... FinancialBuzz.com News Commentary  ... According to a new report by Arcview Market Research, the ... 34 percent to $6.7 billion and can be expected to grow at ... five years, from $6.7 billion in 2016, to $22.6 billion in 2021. ... to purchase cannabis without a doctor,s recommendation. Voters in California ...
(Date:3/27/2017)... 2017 The staggering cost of cancer treatment ... access to the latest treatment options against cancer. Even ... patients have inadequate or no health insurance and are ... Access to modern cancer treatment is almost non-existent for ... The mission statements of pharmaceutical and biotech companies ...
Breaking Medicine Technology: